The neurotoxic effect of amyloid-beta peptide (1-42) was investigated in cultures of neuronal tissue derived from the basal forebrain of embryonic rat. The axonal varicosities of the cholinergic cells were revealed by vesicular acetylcholine transporter staining, and the axonal varicosities in general by synaptophysin immunohistochemistry. The results demonstrate that the treatment of in vitro neuronal cultures with 20 mM amyloid-beta peptide (1-42) for 2 days on day 5, 12 or 15 exerted a neurotoxic effect on both the cholinergic and the non-cholinergic neurons. In the same cultures, the absolute number of synaptophysin-positive axon varicosities was reduced to greater extent (control: 203 ± 37/field vs treated: 101 ± 16/field) than the num...
beta-Amyloid((1-42)) peptide (beta AP((1-42))) was injected into the medial septum of rats. After a ...
Accumulating evidence supports the hypothesis that beta-amyloid (PA) plays a role in the degeneratio...
The dysfunction and loss of basal forebrain cholinergic neurons and their cortical projections are a...
β-Amyloid(1-42) peptide (βAP) was injected into the right nucleus basalis magnocellularis (nbm) of r...
β-Amyloid(1-42) peptide (βAP(1-42)) was injected into the medial septum of rats. After a 14-day surv...
beta-Amyloid((1-42)) peptide (beta AP) was injected into the right nucleus basalis magnocellularis (...
The effects on cholinergic, excitatory amino acid and neuropeptide markers in the basal forebrain of...
Long-term behavioral effects, changes in learning and memory functions and aberrations of cholinergi...
Long-term behavioral effects, changes in learning and memory functions and aberrations of cholinergi...
Alzheimer’s disease (AD) is regarded as a multifactorial disease characterized by a complex pathogen...
The effect of cholinergic basal forebrain lesions on immunoreactivity to somatostatin (SOM-i) and ne...
beta-Amyloid((1-42)) peptide (beta AP((1-42))) was injected into the medial septum of rats. After a ...
Accumulating evidence supports the hypothesis that beta-amyloid (PA) plays a role in the degeneratio...
The dysfunction and loss of basal forebrain cholinergic neurons and their cortical projections are a...
β-Amyloid(1-42) peptide (βAP) was injected into the right nucleus basalis magnocellularis (nbm) of r...
β-Amyloid(1-42) peptide (βAP(1-42)) was injected into the medial septum of rats. After a 14-day surv...
beta-Amyloid((1-42)) peptide (beta AP) was injected into the right nucleus basalis magnocellularis (...
The effects on cholinergic, excitatory amino acid and neuropeptide markers in the basal forebrain of...
Long-term behavioral effects, changes in learning and memory functions and aberrations of cholinergi...
Long-term behavioral effects, changes in learning and memory functions and aberrations of cholinergi...
Alzheimer’s disease (AD) is regarded as a multifactorial disease characterized by a complex pathogen...
The effect of cholinergic basal forebrain lesions on immunoreactivity to somatostatin (SOM-i) and ne...
beta-Amyloid((1-42)) peptide (beta AP((1-42))) was injected into the medial septum of rats. After a ...
Accumulating evidence supports the hypothesis that beta-amyloid (PA) plays a role in the degeneratio...
The dysfunction and loss of basal forebrain cholinergic neurons and their cortical projections are a...